Found: 11
Select item for more details and to access through your institution.
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14197, doi. 10.3390/ijms232214197
- By:
- Publication type:
- Article
Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231161412
- By:
- Publication type:
- Article
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1083297
- By:
- Publication type:
- Article
Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience.
- Published in:
- Journal of Oncology, 2021, p. 1, doi. 10.1155/2021/5548252
- By:
- Publication type:
- Article
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.882896
- By:
- Publication type:
- Article
Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 703, doi. 10.3390/cancers15030703
- By:
- Publication type:
- Article
Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 96, doi. 10.3390/cancers15010096
- By:
- Publication type:
- Article
The Impact of Lifestyle Interventions in High-Risk Early Breast Cancer Patients: A Modeling Approach from a Single Institution Experience.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5539, doi. 10.3390/cancers13215539
- By:
- Publication type:
- Article
Cancer patient perspective in the arena of COVID‐19 pandemic.
- Published in:
- Psycho-Oncology, 2022, v. 31, n. 1, p. 39, doi. 10.1002/pon.5774
- By:
- Publication type:
- Article
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Long-responders to anti-HER2 therapies: A case report and review of the literature.
- Published in:
- Molecular & Clinical Oncology, 2018, v. 8, n. 1, p. 147, doi. 10.3892/mco.2017.1495
- By:
- Publication type:
- Article